Commonwealth Equity Services’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-5,495
| Closed | -$205K | – | 2836 |
|
2018
Q2 | $205K | Buy |
+5,495
| New | +$205K | ﹤0.01% | 2446 |
|
2018
Q1 | – | Sell |
-6,203
| Closed | -$213K | – | 2765 |
|
2017
Q4 | $213K | Buy |
6,203
+593
| +11% | +$20.4K | ﹤0.01% | 2318 |
|
2017
Q3 | $203K | Buy |
+5,610
| New | +$203K | ﹤0.01% | 2274 |
|
2016
Q1 | – | Sell |
-5,143
| Closed | -$222K | – | 2244 |
|
2015
Q4 | $222K | Buy |
+5,143
| New | +$222K | ﹤0.01% | 1809 |
|
2015
Q3 | – | Sell |
-7,145
| Closed | -$243K | – | 2196 |
|
2015
Q2 | $243K | Sell |
7,145
-1,095
| -13% | -$37.2K | ﹤0.01% | 1786 |
|
2015
Q1 | $292K | Buy |
8,240
+1,036
| +14% | +$36.7K | ﹤0.01% | 1657 |
|
2014
Q4 | $245K | Sell |
7,204
-728
| -9% | -$24.8K | ﹤0.01% | 1704 |
|
2014
Q3 | $306K | Sell |
7,932
-1,131
| -12% | -$43.6K | ﹤0.01% | 1540 |
|
2014
Q2 | $353K | Buy |
+9,063
| New | +$353K | ﹤0.01% | 1436 |
|